Healthy Skepticism Library item: 6681

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Re: the promotion of Ponstan (mefenamic acid)
MaLAM disagrees with the conclusion of the IFPMA regarding the complaint about the advertising of Ponstan (mefenamic acid) in Pakistan. 1996 Jul;

Abstract:

MaLAM disagrees with the conclusion of the IFPMA regarding the complaint about the advertising of Ponstan (mefenamic acid) in Pakistan.

Keywords:
*analysis/Pakistan/developing countries/IFPMA/ Code of Pharmaceutical Marketing Practices (IFPMA)/ International Federation of Pharmaceutical Manufacturers Associations/Ponstan/MaLAM/Medical Lobby for Appropriate Marketing/antipyretics/children/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/REGULATION, CODES, GUIDELINES: INDUSTRY SELF-REGULATION